BIJHANS
New to Zerodha? Sign-up for free.
New to Zerodha? Sign-up for free.
Get instant stock alerts
- Share Price
- Financials
- Revenue mix
- Shareholdings
- Peers
- Forensics
Share Price
Coming soon
- 5D
- 1M
- 6M
- YTD
- 1Y
- 5Y
- MAX
Financials
-
Summary
-
Profit & Loss
-
Balance sheet
-
Cashflow
| (In Cr.) |
|---|
| (In Cr.) | ||||
|---|---|---|---|---|
|
This data is currently unavailable for this company. |
| (In %) |
|---|
| (In Cr.) |
|---|
| Financial Year (In Cr.) |
|---|
Revenue mix
-
Product wise
-
Location wise
Revenue Mix
This data is currently unavailable for this company.
Revenue Mix
This data is currently unavailable for this company.
Forensics
Recent events
-
News
-
Corporate Actions
Bijoy Hans Gets Administrative Warning Letter From SEBI
July 17 (Reuters) - Bijoy Hans Ltd BIJH.BO:
GETS ADMINISTRATIVE WARNING LETTER FROM SEBI
Source text: [ID:]
Further company coverage: BIJH.BO
July 17 (Reuters) - Bijoy Hans Ltd BIJH.BO:
GETS ADMINISTRATIVE WARNING LETTER FROM SEBI
Source text: [ID:]
Further company coverage: BIJH.BO
Bijoy Hans To Issue Shares Worth Up To 56.3 Million Rupees
Dec 26 (Reuters) - Bijoy Hans Ltd BIJH.BO:
BIJOY HANS - ISSUANCE OF SHARES WORTH UP TO 56.3 MILLION RUPEES
Source text: ID:nBSE66qMJ0
Further company coverage: BIJH.BO
Dec 26 (Reuters) - Bijoy Hans Ltd BIJH.BO:
BIJOY HANS - ISSUANCE OF SHARES WORTH UP TO 56.3 MILLION RUPEES
Source text: ID:nBSE66qMJ0
Further company coverage: BIJH.BO
Upcoming Events:
Quarterly Results
Events:
More Nano Cap Ideas
See similar 'Nano' cap companies with recent activity
Promoter Buying
Companies where the promoters are bullish
Capex
Companies investing on expansion
Superstar Investor
Companies where well known investors have invested
Popular questions
-
Business
-
Financials
-
Share Price
-
Shareholdings
What does Arvaya Healthcare do?
Bijoy Hans Limited, a company based in Guwahati, India, specializes in trading bulk drugs and pharmaceutical raw materials, along with involvement in investment activities.
Who are the competitors of Arvaya Healthcare?
Arvaya Healthcare major competitors are Rotographics (India), Shiv Texchem, Shankar Lal Rampal, Khemani Distributors, Brand Concepts, Evexia Lifecare, Dynamic Serv & Secu. Market Cap of Arvaya Healthcare is ₹278 Crs. While the median market cap of its peers are ₹278 Crs.
Is Arvaya Healthcare financially stable compared to its competitors?
Arvaya Healthcare seems to be financially stable compared to its competitors. The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.
Does Arvaya Healthcare pay decent dividends?
The company seems to be paying a very low dividend. Investors need to see where the company is allocating its profits. Arvaya Healthcare latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%
How has Arvaya Healthcare allocated its funds?
Companies resources are allocated to majorly unproductive assets like Cash & Short Term Investments
How strong is Arvaya Healthcare balance sheet?
Balance sheet of Arvaya Healthcare is strong. It shouldn't have solvency or liquidity issues.
Is the profitablity of Arvaya Healthcare improving?
The profit is oscillating. The profit of Arvaya Healthcare is -₹0.93 Crs for TTM, ₹0.14 Crs for Mar 2025 and -₹0.12 Crs for Mar 2024.
Is the debt of Arvaya Healthcare increasing or decreasing?
Yes, The net debt of Arvaya Healthcare is increasing. Latest net debt of Arvaya Healthcare is -₹1.35 Crs as of Sep-25. This is greater than Mar-25 when it was -₹5.37 Crs.
Is Arvaya Healthcare stock expensive?
There is insufficient historical data to gauge this. Latest PE of Arvaya Healthcare is 0
Has the share price of Arvaya Healthcare grown faster than its competition?
Arvaya Healthcare has given better returns compared to its competitors. Arvaya Healthcare has grown at ~140.12% over the last 1yrs while peers have grown at a median rate of -28.95%
Is the promoter bullish about Arvaya Healthcare?
Promoters seem not to be bullish about the company and have been selling shares in the open market. Latest quarter promoter holding in Arvaya Healthcare is 30.62% and last quarter promoter holding is 62.73%
Are mutual funds buying/selling Arvaya Healthcare?
There is Insufficient data to gauge this.